-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
February 15, 2013
Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2013 earnings per American Depositary Share (ADS) of 40 ...
-
February 12, 2013
Regeneron Pharmaceuticals, Inc. (REGN) recently announced that it has received a notification under the ...
-
February 12, 2013
Perrigo Company (PRGO) recently announced that it is set to acquire a UK-based privately held pharmaceutical ...
-
February 11, 2013
Warner Chilcott (WCRX) recently revealed its financial guidance for 2013. The company expects to earn $3.20-$3.30 ...
-
February 08, 2013
Recently, Warner Chilcott plc (WCRX) received encouraging news when the US Food and Drug Administration (FDA) ...
-
February 08, 2013
Avanir Pharmaceuticals, Inc. (AVNR) reported first quarter fiscal 2013 net loss per share of 9 cents, wider than the ...
-
February 07, 2013
Recently, Sanofi (SNY) received encouraging news with the European Commission (EC) approving its diabetes candidate, ...
-
February 07, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that data from the pivotal phase III trials, IMPRESS (The ...
-
February 07, 2013
Elan Corporation (ELN) reported earnings of 15 cents per share for the fourth quarter of 2012 compared to the ...
-
February 07, 2013
GlaxoSmithKline (GSK) reported fourth quarter earnings of 57 cents per ADS, missing the Zacks Consensus Estimate of ...
-
February 06, 2013
ArQule, Inc. (ARQL) and partner Daiichi Sankyo recently announced that former has enrolled the first patient for the ...
-
February 06, 2013
Recently Sanofi (SNY) and partner Regeneron Pharmaceuticals Inc. (REGN) received encouraging news with the European ...
-
February 06, 2013
Good news flowed in at UCB (UCBJF) from Europe when the European Union (EU) approved Vimpat (lacosamide) as a single ...
-
February 04, 2013
Seattle Genetics Inc. (SGEN) recently received approval from Health Canada for its oncology drug, Adcetris ...
-
February 04, 2013
Elan Corporation plc (ELN) recently decided to sell its remaining 7.8 million ordinary shares in Alkermes plc (ALKS) ...
-
February 04, 2013
Valeant Pharmaceuticals International, Inc. (VRX) recently closed the acquisition of Russia-based Natur Produkt ...
-
January 31, 2013
Endocyte Inc. (ECYT) recently announced that its oncology candidate, EC0652, achieved key objectives in a phase 0 ...
-
January 30, 2013
Anacor Pharmaceuticals, Inc. (ANAC) recently announced positive preliminary results on tavaborole (AN2690) from ...
-
January 30, 2013
Santarus, Inc. (SNTS) recently filed a patent infringement lawsuit against Mylan, Inc. (MYL) which is looking to ...
